[1]
Tuxen, M.K. et al. 2014. Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer. Acta Oncologica. 53, 10 (Oct. 2014), 1440–1445. DOI:https://doi.org/10.3109/0284186X.2014.921727.